Iversil 12 Tablet contains Ivermectin 12 mg, an antiparasitic agent widely used for the treatment of various parasitic infections. Ivermectin acts by binding selectively and with high affinity to glutamate-gated chloride ion channels found in invertebrate nerve and muscle cells, leading to increased permeability to chloride ions, hyperpolarization, and subsequent paralysis and death of the parasite. This medication is primarily indicated for the treatment of strongyloidiasis, onchocerciasis, and other infections caused by susceptible parasites such as certain types of roundworms, scabies, and lice. Iversil 12 Tablet is administered orally, with dosage and duration dependent on the specific infection and patient factors such as weight and clinical condition. It is generally well tolerated; however, some patients may experience adverse effects including dizziness, nausea, diarrhea, or mild skin reactions. Caution is advised in patients with impaired liver function or those on concomitant medications that may interact with ivermectin. Iversil 12 should be used under medical supervision, and it is contraindicated in patients with known hypersensitivity to ivermectin or any of its excipients. Proper diagnosis and adherence to prescribed dosage are essential to ensure therapeutic efficacy and minimize the risk of resistance or adverse events.